Literature DB >> 16688227

Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL.

G Strathdee, A Sim, A Parker, D Oscier, R Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16688227     DOI： 10.1038/sj.leu.2404254

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia.

Authors:  Lirong Pei; Jeong-Hyeon Choi; Jimei Liu; Eun-Joon Lee; Brian McCarthy; James M Wilson; Ethan Speir; Farrukh Awan; Hongseok Tae; Gerald Arthur; Jennifer L Schnabel; Kristen H Taylor; Xinguo Wang; Dong Xu; Han-Fei Ding; David H Munn; Charles Caldwell; Huidong Shi
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

Review 2.  DNA methylation: its role in cancer development and therapy.

Authors:  Carla Kurkjian; Shivaani Kummar; Anthony J Murgo
Journal:  Curr Probl Cancer       Date:  2008 Sep-Oct       Impact factor: 3.187

Review 3.  Uncovering the DNA methylome in chronic lymphocytic leukemia.

Authors:  Nicola Cahill; Richard Rosenquist
Journal:  Epigenetics       Date:  2013-01-15       Impact factor: 4.528

4.  Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia.

Authors:  Laura Irving; Tryfonia Mainou-Fowler; Anton Parker; Rachel E Ibbotson; David G Oscier; Gordon Strathdee
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

5.  Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2.

Authors:  Sujata Bhoi; Viktor Ljungström; Panagiotis Baliakas; Mattias Mattsson; Karin E Smedby; Gunnar Juliusson; Richard Rosenquist; Larry Mansouri
Journal:  Epigenetics       Date:  2016-04-29       Impact factor: 4.528

6.  Aberrant DNA methylation at HOXA4 and HOXA5 genes are associated with resistance to imatinib mesylate among chronic myeloid leukemia patients.

Authors:  Marjanu Hikmah Elias; Husin Azlan; Sarina Sulong; Abdul Aziz Baba; Ravindran Ankathil
Journal:  Cancer Rep (Hoboken)       Date:  2018-07-27

7.  Symmetrical Dose-Dependent DNA-Methylation Profiles in Children with Deletion or Duplication of 7q11.23.

Authors:  Emma Strong; Darci T Butcher; Rajat Singhania; Carolyn B Mervis; Colleen A Morris; Daniel De Carvalho; Rosanna Weksberg; Lucy R Osborne
Journal:  Am J Hum Genet       Date:  2015-07-09       Impact factor: 11.025

8.  Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.

Authors:  Meena Kanduri; Millaray Marincevic; Anna M Halldórsdóttir; Larry Mansouri; Katarina Junevik; Stavroula Ntoufa; Hanna Göransson Kultima; Anders Isaksson; Gunnar Juliusson; Per-Ola Andersson; Hans Ehrencrona; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Epigenetics       Date:  2012-11-15       Impact factor: 4.528

9.  HOXA4 gene promoter hypermethylation as an epigenetic mechanism mediating resistance to imatinib mesylate in chronic myeloid leukemia patients.

Authors:  Marjanu Hikmah Elias; Abdul Aziz Baba; Azlan Husin; Sarina Sulong; Rosline Hassan; Goh Ai Sim; S Fadilah Abdul Wahid; Ravindran Ankathil
Journal:  Biomed Res Int       Date:  2012-12-26       Impact factor: 3.411

10.  Using cell fate attractors to uncover transcriptional regulation of HL60 neutrophil differentiation.

Authors:  Albert C Huang; Limei Hu; Stuart A Kauffman; Wei Zhang; Ilya Shmulevich
Journal:  BMC Syst Biol       Date:  2009-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.